GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Health Sciences Acquisitions Corp 2 (NAS:HSAQ) » Definitions » PE Ratio (TTM)

Health Sciences Acquisitions 2 (Health Sciences Acquisitions 2) PE Ratio (TTM) : At Loss (As of May. 07, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Health Sciences Acquisitions 2 PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-05-07), Health Sciences Acquisitions 2's share price is $13.31. Health Sciences Acquisitions 2's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was $-0.18. Therefore, Health Sciences Acquisitions 2's PE Ratio (TTM) for today is At Loss.


The historical rank and industry rank for Health Sciences Acquisitions 2's PE Ratio (TTM) or its related term are showing as below:

HSAQ' s PE Ratio (TTM) Range Over the Past 10 Years
Min: At Loss   Med: At Loss   Max: At Loss
Current: At Loss



HSAQ's PE Ratio (TTM) is not ranked
in the Diversified Financial Services industry.
Industry Median: 49.22 vs HSAQ: At Loss

Health Sciences Acquisitions 2's Earnings per Share (Diluted) for the three months ended in Dec. 2022 was $-0.07. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was $-0.18.

As of today (2024-05-07), Health Sciences Acquisitions 2's share price is $13.31. Health Sciences Acquisitions 2's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2022 was $-0.18. Therefore, Health Sciences Acquisitions 2's PE Ratio without NRI for today is At Loss.

Health Sciences Acquisitions 2's EPS without NRI for the three months ended in Dec. 2022 was $-0.07. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2022 was $-0.18.

Health Sciences Acquisitions 2's EPS (Basic) for the three months ended in Dec. 2022 was $-0.07. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2022 was $-0.18.


Health Sciences Acquisitions 2 PE Ratio (TTM) Historical Data

The historical data trend for Health Sciences Acquisitions 2's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health Sciences Acquisitions 2 PE Ratio (TTM) Chart

Health Sciences Acquisitions 2 Annual Data
Trend Dec20 Dec21 Dec22
PE Ratio (TTM)
N/A At Loss At Loss

Health Sciences Acquisitions 2 Quarterly Data
May20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison of Health Sciences Acquisitions 2's PE Ratio (TTM)

For the Shell Companies subindustry, Health Sciences Acquisitions 2's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Sciences Acquisitions 2's PE Ratio (TTM) Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Health Sciences Acquisitions 2's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Health Sciences Acquisitions 2's PE Ratio (TTM) falls into.



Health Sciences Acquisitions 2 PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Health Sciences Acquisitions 2's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=13.31/-0.180
=At Loss

Health Sciences Acquisitions 2's Share Price of today is $13.31.
Health Sciences Acquisitions 2's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.18.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Health Sciences Acquisitions 2  (NAS:HSAQ) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Health Sciences Acquisitions 2 PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of Health Sciences Acquisitions 2's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Health Sciences Acquisitions 2 (Health Sciences Acquisitions 2) Business Description

Traded in Other Exchanges
N/A
Address
40, 10th Avenue, Floor 7, New York, NY, USA, 10014
Website
Health Sciences Acquisitions Corp 2 is a blank check company.
Executives
Joshua Aiello officer: See Remarks 150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Eric S Fain director ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN MN
Yuval Mika officer: See Remarks 150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Jason Aryeh director 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
David P Hochman director, officer: See Remarks 15 WESTON HILL RD., RIVERSIDE CT 06878
Geoffrey Wade Smith director 6740 SHADY OAK ROAD, EDEN PRAIRIE MN 55344
Pamela Ann Connealy director 320 W 37TH STREET, 3RD FLOOR, NEW YORK NY 10016
Rose Eric A Md director 161 FORT WASHINGTON AVENUE, 7TH FLOOR, NEW YORK NY 10032
Plc Medtronic 10 percent owner 20 ON HATCH, LOWER HATCH STREET, DUBLIN L2 2
Michael Kaswan officer: Chief Financial Officer KBL HEALTHCARE ACQUISITION CORP II, 645 MADISON AVENUE, NEW YORK NY 10022
Darren Sherman director, officer: See Remarks C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Roderick Wong director, 10 percent owner, officer: Chief Executive Officer C/O RTW INVESTMENTS, LP, 40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014
Rtw Investments, Lp 10 percent owner 40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014
Hsac 2 Holdings, Llc 10 percent owner 412 WEST 15TH STREET, FLOOR 9, NEW YORK NY 10011
Stephanie A Sirota officer: VP-Corp Strategy & Corp Comms. 412 WEST 15TH STREET, FLOOR 9, NEW YORK NY 10011